◀ Figure EV1 . Physical interaction of Gal-3 and Gal-1 with CC and CXC chemokines.
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Gal-3 CRD CCL Figure Gal-3 chip Gal-3 chip Gal-3 chip ◀ Figure EV4 . Co-localization of CXCL12 and Gal-3 on cells in vivo.
A, B Proximity of Gal-3 and CXCL12 on cells from peritoneal lavages after injection of (A) PBS or (B) TG was determined by PLA (representative example of n = 3). White scale bar: 10 lm. C, D Co-localization of Gal-3 and CXCL12 in frozen sections of lymph nodes from (C) WT and (D) CXCL12 À/À mice was determined by immunofluorescence staining using antibodies against Gal-3 and CXCL12 (representative example of n = 3). Scale bar: 40 lm. Arrows indicate subcapsular sinus macrophages (SSM). E Co-localization on the same sections was also detected by PLA (representative example of n = 3). Scale bar: 40 lm. ◀ Figure EV5 . MD simulation of a ternary complex between CXCL12, Gal-3 CRD, and CXCR4 in a lipid bilayer environment.
Complex 6 was superimposed onto the viral chemokine antagonist vMIP-II in complex with CXCR4 (PDB access code 4RWS). Subsequently, the viral chemokine antagonist vMIP-II was deleted, and the complex between monomeric CXCR4 in complex with the CXCL12/Gal-3 CRD heterodimer was obtained. This model was refined by energy minimization in the course of MD simulations (50 ns) with coordinates and orientation from another monomer of CXCR4 (CXCR4 as dimer (PDB access code 3ODU), monomers in cyan and yellow, CXCL12 in magenta, and Gal-3 CRD in light green). The inset shows that N180 (Gal-3 CRD) forms H-bonds (dashed red lines) with N97 (CXCR4) and R183 (Gal-3 CRD) can do so with E31 (CXCR4) and with R8 (CXCL12). 
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